staurosporine has been researched along with sb 216763 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Addo, MF; Andrade-Gordon, P; Conway, BR; Demarest, KT; Derian, CK; Eckardt, AJ; Emanuel, S; Look, R; Maryanoff, BE; McComsey, DF; Westover, L; White, KB; Xu, JZ; Ye, H; Zhang, HC | 1 |
| Flajolet, M; Greengard, P; Meijer, L | 1 |
| Jagarlapudi, SA; Sinha, BN; Tajne, S; Vadivelan, S | 1 |
| Billadeau, DD; Blond, SY; Gaisina, IN; Gallier, F; Guo, S; Holzle, D; Kim, KH; Kozikowski, AP; Kurome, T; Luchini, DN; Ougolkov, AV | 1 |
| Dai, WB; Rakesh, KP; Wang, SL; Wu, PY; Xu, M; Zhu, L | 1 |
2 review(s) available for staurosporine and sb 216763
| Article | Year |
|---|---|
Pharmacological inhibitors of glycogen synthase kinase 3.
Topics: Animals; Cell Differentiation; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Humans; Neoplasms; Nervous System Diseases; Parasitic Diseases; Signal Transduction; Stem Cells; Structure-Activity Relationship | 2004 |
Structure-activity relationship (SAR) studies of synthetic glycogen synthase kinase-3β inhibitors: A critical review.
Topics: Glycogen Synthase Kinase 3 beta; Humans; Molecular Structure; Protein Binding; Protein Kinase Inhibitors; Structure-Activity Relationship | 2019 |
3 other study(ies) available for staurosporine and sb 216763
| Article | Year |
|---|---|
Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3.
Topics: Antineoplastic Agents; Cell Line; Cyclization; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Inhibitory Concentration 50; Isoenzymes; Maleimides; Protein Kinase C; Protein Kinase C beta; Structure-Activity Relationship | 2003 |
Fragment and knowledge-based design of selective GSK-3beta inhibitors using virtual screening models.
Topics: Algorithms; Computer Simulation; Databases, Factual; Drug Design; Drug Evaluation, Preclinical; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Models, Chemical; Models, Molecular; Molecular Structure; Oxazines; Protein Kinase Inhibitors; Quinazolines; Reproducibility of Results; Stereoisomerism; Structure-Activity Relationship | 2009 |
From a natural product lead to the identification of potent and selective benzofuran-3-yl-(indol-3-yl)maleimides as glycogen synthase kinase 3beta inhibitors that suppress proliferation and survival of pancreatic cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Benzofurans; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase 2; Drug Screening Assays, Antitumor; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Maleimides; Models, Molecular; Pancreatic Neoplasms; Structure-Activity Relationship; X-Linked Inhibitor of Apoptosis Protein | 2009 |